The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2A
Abstract
Although the biological actions of the cell membrane and serum lipid lysophosphatidylcholine (LPC) in atherosclerosis and systemic autoimmune disease are well recognized, LPC has not been linked to a specific cell-surface receptor. We show that LPC is a high-affinity ligand for G2A, a lymphocyte-expressed G protein–coupled receptor whose genetic ablation results in the development of autoimmunity. Activation of G2A by LPC increased intracellular calcium concentration, induced receptor internalization, activated ERK mitogen-activated protein kinase, and modified migratory responses of Jurkat T lymphocytes. This finding implicates a role for LPC-G2A interaction in the etiology of inflammatory autoimmune disease and atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
Xu, Y., Zhu, K., Hong, G., Wu, W., Baudhuin, L. M., Xiao, Y.-J., & Damron, D. S. (2000) · Nature Cell Biology · doi:10.1038/35010529 · Cited by 289
Self-citationRetractedLusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Kume, N., Cybulsky, M. I., & Gimbrone, M. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115932 · Cited by 824
Bioactive Lysophospholipids and Their G Protein-Coupled Receptors
Moolenaar, W. H. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4702 · Cited by 407
Kume, N., & Gimbrone, M. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117047 · Cited by 329
Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes.
McMurray, H. F., Parthasarathy, S., & Steinberg, D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116605 · Cited by 252
Sphingolipid metabolites: Members of a new class of lipid second messengers
Spiegel, S., & Milstien, S. (1995) · The Journal of Membrane Biology · doi:10.1007/bf00233943 · Cited by 223
Mice Lacking the Orphan G Protein-Coupled Receptor G2A Develop a Late-Onset Autoimmune Syndrome
Le, L. Q., Kabarowski, J. H. S., Weng, Z., Satterthwaite, A. B., Harvill, E. T., Jensen, E. R., Miller, J. F., & Witte, O. N. (2001) · Immunity · doi:10.1016/s1074-7613(01)00145-5 · Cited by 215
Self-citationAmberger, A., Maczek, C., Jürgens, G., Michaelis, D., Schett, G. A., Trieb, K., Eberl, T., Jindal, S., Xu, Q., & Wick, G. (1997) · Cell Stress and Chaperones · doi:10.1379/1466-1268(1997)002<0094:ceoive>2.3.co;2 · Cited by 192
Identification of a Molecular Target of Psychosine and Its Role in Globoid Cell Formation
Im, D.-S., Heise, C. E., Nguyen, T., O'Dowd, B. F., & Lynch, K. R. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.2.429 · Cited by 190
Cited by
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Lauber, K., Bohn, E., Kröber, S. M., Xiao, Y.-J., Blumenthal, S. G., Lindemann, R. K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00422-7 · Cited by 967
Self-citationGardella, S., Andrei, C., Ferrera, D., Lotti, L. V., Torrisi, M. R., Bianchi, M. E., & Rubartelli, A. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf198 · Cited by 926
Lysophospholipid Receptors: Signaling and Biology
Ishii, I., Fukushima, N., Ye, X., & Chun, J. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073731 · Cited by 771
LAULAGNIER, K., MOTTA, C., HAMDI, S., ROY, S., FAUVELLE, F., PAGEAUX, J.-F., KOBAYASHI, T., SALLES, J.-P., PERRET, B., BONNEROT, C., et al. (2004) · Biochemical Journal · doi:10.1042/bj20031594 · Cited by 647
Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies
Subra, C., Laulagnier, K., Perret, B., & Record, M. (2007) · Biochimie · doi:10.1016/j.biochi.2006.10.014 · Cited by 619
The mechanisms of lysophosphatidylcholine in the development of diseases
Liu, P., Zhu, W., Chen, C., Yan, B., Zhu, L., Chen, X., & Peng, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117443 · Cited by 579
Lauber, K., Blumenthal, S. G., Waibel, M., & Wesselborg, S. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00237-0 · Cited by 557
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Lysophospholipids--Receptor Revelations
Hla, T., Lee, M.-J., Ancellin, N., Paik, J. H., & Kluk, M. J. (2001) · Science · doi:10.1126/science.1065323 · Cited by 537
Zalewski, A., & Macphee, C. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160551.21962.a7 · Cited by 474
International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature
Chun, J., Goetzl, E. J., Hla, T., Igarashi, Y., Lynch, K. R., Moolenaar, W., Pyne, S., & Tigyi, G. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.265 · Cited by 464
The ‘cytokine profile’: a code for sepsis
Ulloa, L., & Tracey, K. J. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.007 · Cited by 440
Brown, A. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707481 · Cited by 409
Toll‐like receptors, endogenous ligands, and systemic autoimmune disease
Rifkin, I. R., Leadbetter, E. A., Busconi, L., Viglianti, G., & Marshak‐Rothstein, A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00239.x · Cited by 389
Lysophospholipid receptors: Signalling, pharmacology and regulation by lysophospholipid metabolism
Meyer zu Heringdorf, D., & Jakobs, K. H. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.026 · Cited by 388
Emerging roles of lysophospholipids in health and disease
Tan, S. T., Ramesh, T., Toh, X. R., & Nguyen, L. N. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101068 · Cited by 371
Soga, T., Ohishi, T., Matsui, T., Saito, T., Matsumoto, M., Takasaki, J., Matsumoto, S.-I., Kamohara, M., Hiyama, H., Yoshida, S., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.120 · Cited by 367
Target validation of G-protein coupled receptors
Wise, A., Gearing, K., & Rees, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02131-6 · Cited by 359
Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients
Drobnik, W., Liebisch, G., Audebert, F.-X., Fröhlich, D., Glück, T., Vogel, P., Rothe, G., & Schmitz, G. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200401-jlr200 · Cited by 350
Chun, J., Hla, T., Lynch, K. R., Spiegel, S., & Moolenaar, W. H. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003111 · Cited by 330
Therapeutic effects of lysophosphatidylcholine in experimental sepsis
Yan, J.-J., Jung, J.-S., Lee, J.-E., Lee, J., Huh, S.-O., Kim, H.-S., Jung, K. C., Cho, J.-Y., Nam, J.-S., Suh, H.-W., et al. (2004) · Nature Medicine · doi:10.1038/nm989 · Cited by 329
Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay
Yin, H., Chu, A., Li, W., Wang, B., Shelton, F., Otero, F., Nguyen, D. G., Caldwell, J. S., & Chen, Y. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806516200 · Cited by 311
Migration to Apoptotic “Find-me” Signals Is Mediated via the Phagocyte Receptor G2A
Peter, C., Waibel, M., Radu, C. G., Yang, L. V., Witte, O. N., Schulze-Osthoff, K., Wesselborg, S., & Lauber, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706586200 · Cited by 258
Self-citationLysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes
Han, M. S., Park, S. Y., Shinzawa, K., Kim, S., Chung, K. W., Lee, J.-H., Kwon, C. H., Lee, K.-W., Lee, J.-H., Park, C. K., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700184-jlr200 · Cited by 257
Development and selection of marginal zone B cells
Lopes‐Carvalho, T., & Kearney, J. F. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0112.x · Cited by 253
G2A Is a Proton-sensing G-protein-coupled Receptor Antagonized by Lysophosphatidylcholine
Murakami, N., Yokomizo, T., Okuno, T., & Shimizu, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406561200 · Cited by 252
Palm, N. W., Rosenstein, R. K., Yu, S., Schenten, D. D., Florsheim, E., & Medzhitov, R. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.006 · Cited by 214
Chun, J., Kihara, Y., Jonnalagadda, D., & Blaho, V. A. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021358 · Cited by 131
Oxidized phospholipids in control of inflammation and endothelial barrier
Fu, P., & Birukov, K. G. (2009) · Translational Research · doi:10.1016/j.trsl.2008.12.005 · Cited by 86
Esteras, N., Bartolomé, F., Alquézar, C., Antequera, D., Muñoz, Ú., Carro, E., & Martín‐Requero, Á. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08178.x · Cited by 30
Peng, J., Cai, S., Wang, L., Zhao, N., Zhang, T.-J., Chen, Z.-X., & Meng, F.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090416 · Cited by 8
Metadata
- Authors
- Kabarowski, J. H. S., Zhu, K., Le, L. Q., Witte, O. N., & Xu, Y.
- Venue
- Science
- Published
- 2001-07-27
- Volume
- 293
- Issue
- 5530
- Pages
- 702-705
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2059511462
- Cited by
- 332
- References
- 20
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.